default author photo

Yao-Jun Zhang

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

Guangzhou, 510060

China

SCHOLARLY PAPERS

3

DOWNLOADS

280

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Development and Validation of Prognostic Nomograms for BCLC A Stage Hepatocellular Carcinoma Beyond Milan Criteria after Curative Resection

Number of pages: 30 Posted: 30 Nov 2020
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-Sen University (SYSU) - Department of Pancreato-Biliary Surgery, Hunan Normal University - Department of General Surgery, Hunan Normal University - Department of Hepatobiliary Surgery, Jinan University - Department of Neurology and Stroke Center, Jinan University - Department of General Surgery, Southern Medical University - Department of Hepatobiliary Surgery, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Government of the People's Republic of China - Department of Interventional Ultrasound and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 157 (474,889)

Abstract:

Loading...

Hepatocellular carcinoma; Liver resection; Nomogram; BCLC A stage

2.

Immune Checkpoint Inhibitors, Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib or Bevacizumab in Unresectable Hepatocellular Carcinoma: A Retrospective, Multi-Center, and Propensity Score Matching Study

Number of pages: 30 Posted: 16 Jul 2024
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Guangzhou Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Guangzhou First People's Hospital, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 65 (924,743)

Abstract:

Loading...

Hepatocellular carcinoma, lenvatinib, bevacizumab, combination therapy, conversion resection

3.

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy Versus Sorafenib Plus Transarterial Chemoembolization in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase 3 Trial (Shata-001 Study)

Number of pages: 34 Posted: 06 Apr 2025
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 58 (980,173)

Abstract:

Loading...

Hepatocellular carcinoma, sorafenib, transcatheter arterial chemoembolization, hepatic arterial infusion chemotherapy, biomolecular exploratory, phosphofructokinase